Outcomes of Patients With an Ultra-Low–Risk 70-Gene Signature in the MINDACT Trial

Posted: 03/07/2022 | By: Melissa E. Fryman, MS

Question 1 of 5

Patients with 70-gene signature ultra-low–risk breast cancer have excellent survival rates, as shown in:

Choose 1